Dr David Spencer Jackson, MD | |
11055 Little Patuxent Pkwy, Suite 205, Columbia, MD 21044-2896 | |
(410) 740-0789 | |
(410) 740-7024 |
Full Name | Dr David Spencer Jackson |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 44 Years |
Location | 11055 Little Patuxent Pkwy, Columbia, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891796900 | NPI | - | NPPES |
398140-03 | Other | MD | CAREFIRST MD RENDERING |
4238639 | Other | MD | AETNA FEE FOR SERVICE |
P528953 | Other | MD | CAREFIRST MPOS |
0477972 | Other | MD | AETNA CAPITATED |
478471500 | Medicaid | MD | |
060041579 | Other | MD | RR MEDICARE |
318934 | Other | MD | MAMSI SPECIALIST |
3509-0006 | Other | MD | CAREFIRST BLUECHOICE |
018410 | Other | MD | JHHC PROVIDER NUMBER |
0149212 | Other | MD | CIGNA PIN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | D35217 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Howard County General Hospital | Columbia, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Maryland Primary Care Physicians, Llc | 8729981832 | 91 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, both long and short sleepers are at greater risk for diabetes. Individuals sleeping for more than eight hours per night may be particularly vulnerable.
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
Constantly rising U.S. health care costs could be reduced significantly by preventing and treating neuropathic pain conditions associated with diabetes and herpes zoster virus infections, according to research published in The Journal of Pain, the peer review publication of the American Pain Society, www.ampainsoc.org and jpain.org.
Today Invacare Corporation commented on an FDA warning letter related to an inspection of the Company's bed manufacturing facility in Sanford, Florida. The warning letter takes issue with Invacare's compliance with the FDA's Quality System Regulation, specifically related to Invacare's ability to establish and maintain adequate procedures to analyze processes and operations and to document actions taken on product complaints.
› Verified 4 days ago
Entity Name | Maryland Primary Care Physicians, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083667067 PECOS PAC ID: 8729981832 Enrollment ID: O20040128000134 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, both long and short sleepers are at greater risk for diabetes. Individuals sleeping for more than eight hours per night may be particularly vulnerable.
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
Constantly rising U.S. health care costs could be reduced significantly by preventing and treating neuropathic pain conditions associated with diabetes and herpes zoster virus infections, according to research published in The Journal of Pain, the peer review publication of the American Pain Society, www.ampainsoc.org and jpain.org.
Today Invacare Corporation commented on an FDA warning letter related to an inspection of the Company's bed manufacturing facility in Sanford, Florida. The warning letter takes issue with Invacare's compliance with the FDA's Quality System Regulation, specifically related to Invacare's ability to establish and maintain adequate procedures to analyze processes and operations and to document actions taken on product complaints.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Spencer Jackson, MD 7580 Buckingham Blvd Ste 220, Hanover, MD 21076-3210 Ph: (410) 729-5100 | Dr David Spencer Jackson, MD 11055 Little Patuxent Pkwy, Suite 205, Columbia, MD 21044-2896 Ph: (410) 740-0789 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, both long and short sleepers are at greater risk for diabetes. Individuals sleeping for more than eight hours per night may be particularly vulnerable.
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
Constantly rising U.S. health care costs could be reduced significantly by preventing and treating neuropathic pain conditions associated with diabetes and herpes zoster virus infections, according to research published in The Journal of Pain, the peer review publication of the American Pain Society, www.ampainsoc.org and jpain.org.
Today Invacare Corporation commented on an FDA warning letter related to an inspection of the Company's bed manufacturing facility in Sanford, Florida. The warning letter takes issue with Invacare's compliance with the FDA's Quality System Regulation, specifically related to Invacare's ability to establish and maintain adequate procedures to analyze processes and operations and to document actions taken on product complaints.
› Verified 4 days ago
Dr. Jon Kent Minford, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Dr. Jacob Cherian, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 410-964-5311 Fax: 410-964-8578 | |
Dr. Tejaswi Rajasekhara Sastry, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Michael Howard Kelemen, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Suite 200b, Columbia, MD 21045 Phone: 410-964-5303 | |
Dr. Tin O Maung, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5999 Harpers Farm Rd, Suite W250, Columbia, MD 21044 Phone: 410-772-8822 Fax: 410-772-9274 | |
Dr. Jeffery Wayne Van Den Broek, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 110, Columbia, MD 21044 Phone: 410-992-9797 Fax: 410-730-0942 | |
Angela M. Kopack, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 11055 Little Patuxent Pkwy, Suite 209, Columbia, MD 21044 Phone: 410-884-1311 Fax: 410-884-6033 |